SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotechnology Value Fund, L.P.
An SI Board Since January 1998
Posts SubjectMarks Bans
4974 145 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromPosted
3874Telk file $200mm S-3 register..(eom)mopgcw4/16/2004
3873Yeah, and as a result? We've gotten some weird, science-light companies runscaram(o)uche4/16/2004
3872Investors Focus on Biotechs With Products in the Pipeline By SARAH SPIKES DOW Doc Bones4/16/2004
3871Immunicon IPO is priced at $8 per share Thursday April 15, 6:11 pm ET NEW YORKscaram(o)uche4/15/2004
3870appears so, at least to a degree. thanks for posting that stuff.scaram(o)uche4/14/2004
3869Alexion Pharmaceuticals Registers $150M Mixed Sec Shelf DOW JONES NEWSWIRES Aprmopgcw4/14/2004
3868Window still Open???: Intrabiotics Pharma Files To Sell 3M Common Shares DOW Jmopgcw4/14/2004
3867Corcept Therapeutics IPO Priced 4.5M Shares At $12/Share DOW JONES NEWSWIRES Apmopgcw4/14/2004
3866Cephalon Receives Broad Label for PROVIGIL in the United Kingdom Tuesday April 1scaram(o)uche4/13/2004
3865Corus Pharma Raises $60 Million to Advance Clinical Programs SEATTLE, April 12 nigel bates4/13/2004
3864Avanir Pharma Files To Sell Up To $50M In Class A Stk DOW JONES NEWSWIRES Aprilmopgcw4/13/2004
3863deCODE Prices $125 Million Senior Convertible Notes Offering REYKJAVIK, Icelandnigel bates4/8/2004
3862<<Sales for Avastin(TM) (bevacizumab) were $38.1 million in the first quarMiljenko Zuanic4/7/2004
3861Genentech Announces First Quarter 2004 Results - Increase of 28 Percent in Produscaram(o)uche4/7/2004
3860thestreet.com Genentech May Dazzle Again By Robert Steyer TheStreet.com Staffscaram(o)uche4/7/2004
3859Favrille, Inc. Secures $44 Million in Private Placement Tuesday April 6, 10:59 pnigel bates4/7/2004
3858John: No sweat. Very good of you, and many apart from Harry will also appreciascaram(o)uche4/5/2004
3857Harry - you've probably have this - but if not - maybe there is a goodie or John McCarthy4/5/2004
3856Some SI contributors, when they first landed, didn't understand that construscaram(o)uche4/2/2004
3855<<<(OK, I know someone might throw that comment back in my face..>&grkrw4/2/2004
3854PCYC already has $73m! What, are people stoopid? (OK, I know someone might thrkeokalani'nui4/2/2004
3853Cypress Bioscience, Inc. Announces Pricing Of Common Stock In Public Offering Snigel bates4/2/2004
3852Evotec Neurosciences Completes Euro 25 Million Series A Financing HAMBURG, Germnigel bates4/2/2004
3851GPC Biotech Plans Equity Offering, Nasdaq Listing DOW JONES NEWSWIRES April 2, mopgcw4/2/2004
3850Nucleonics Raises $40.9 Million in Series B Venture Financing MALVERN, Pa.--(BUnigel bates4/1/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News